openPR Logo
Press release

Metabolomics Market will increase $2,500.0 Million in 2021

02-15-2017 08:25 AM CET | Health & Medicine

Press release from: Healthcare: Market Research Store

Metabolomics Market will increase $2,500.0 Million in 2021

Zion Research has published a new report titled “Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics : Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global demand for metabolomics was valued at over USD 675.0 million in 2015 and it is expected to reach above USD 2,500.0 million in 2021, growing at a CAGR of above 25.0% between 2016 and 2021.

Request Sample Report: http://bit.ly/2bepfIs

Metabolomics Market: Overview

Metabolites are substances or compounds found in the cell, they are intermediate products catalyzed by enzymes in the metabolism process. Signaling molecules, hormones, metabolic intermediates and secondary metabolites are some of the types of metabolites. Metabolism is the process to maintain living state of cell. Metabolism can be either anabolism or catabolism. Anabolism is the process in which certain compounds are synthesized that is required for cells to process, while breakdown of molecules for releasing energy is the catabolism. Metabolome is total set of metabolites present in a single organism. Metabolomics is study of chemical reactions related to metabolites and a field of analytical biochemistry. Metabolomics is used to compute and recognize the metabolites present in the cell via analytical technologies together with multi variant and statistical method for data interpretation.

Metabolomics Market: Growth Factors

Increasing scope of toxicological studies, clinical trials, rise in awareness for health and government and institution funds for research is expected to drive the demand for the metabolomics market. Lack of adoption of metabolomics technology and complexity of the process can hamper the metabolomics market. Increasing research and development expenditure and existing demand from emerging economies and is likely to open new market avenues in the near future.

Do Inquiry before buying: http://bit.ly/2evoL2y

Metabolomics Market: Segmentation

The metabolomics market is segmented on the basis of technology, indication, application and region. Mass spectrometry, capillary electrophoresis, high performance liquid chromatography, gas chromatography and nuclear magnetic resonance spectroscopy are some of the major segments based on technology. High performance liquid chromatography was largest technology segment for metabolomics market. Drug discovery, biomarker and nutrigenomics are some of the key application markets for metabolomics. Drug discovery emerged as dominating segment due to its significant role in optimization, prioritization and drug target validation and identification for research. Cardiology and oncology are the indication for metabolomics.

Metabolomics Market: Regional Analysis

North America held 40% share in global market and dominated the metabolomics market in 2015.This region remains competitive with the presence of a large number of vendors. Europe was the second largest market with over 30% share of the total share in the same year. Asia Pacific is expected to witness rapid growth in the years to come.

Metabolomics Market: Competitive Players

Key players in global metabolomics market include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.

Browse the full “Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021” report at http://www.marketresearchstore.com/report/metabolomics-market-z55501

Metabolomics Market: Regional Segment Analysis

This report segments the metabolomics market as follows:

Metabolomics Market: Technology Segment Analysis

High performance liquid chromatography
Mass spectrometry
Capillary electrophoresis
Gas chromatography
Nuclear magnetic resonance spectroscopy
Metabolomics Market: Indication Segment Analysis

Cardiology
Oncology
Metabolomics Market: Application Segment Analysis

Drug discovery
Biomarker
Nutrigenomic
Metabolomics Market: Regional Segment Analysis

North America
US
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa



Similar Reports :-

Browse the full “Nanobiotechnology Market for Drug Discovery, Drug Delivery, Diagnostics and Others: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021” report at http://www.marketresearchstore.com/report/nanobiotechnology-market-z55960

Browse the full “Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021” report at http://www.marketresearchstore.com/report/clinical-trial-imaging-market-z59874

Browse the full “E. Coli Testing (Environmental Testing and Clinical Testing) Market for Diagnostic Laboratories, Hospitals, Waste Water Treatment Organizations, Bottle Water Suppliers And Other End-user: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021” report at http://www.marketresearchstore.com/report/e-coli-testing-market-z60568

About Us

Zion Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact US:

Joel John
3422 SW 15 Street,Suit #8138
Deerfield Beach,Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@marketresearchstore.com
Website: http://www.marketresearchstore.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Metabolomics Market will increase $2,500.0 Million in 2021 here

News-ID: 437932 • Views: 343

More Releases from Healthcare: Market Research Store

E. Coli Testing Market to Record an Impressive Growth $2.0 Bn by 2021
Zion Research has published a new report titled “E. Coli Testing (Membrane Filtration (MF), Enzyme-Substrate Methods, Polymerase Chain Reaction (PCR) Tests, And Others) Market for Diagnostic Laboratories, Hospitals, Waste Water Treatment Organizations, Bottle Water Suppliers And Other End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” According to the report, the global E. coli testing market was valued at around USD 1.2 billion in 2015 and is expected
By 2021, Clinical Trial Imaging Market to generate huge revenue $1,052.9 Million
Zion Research has published a new report titled “Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis And Forecast, 2015 – 2021” According to the report, the global clinical trial imaging market was valued at approximately USD 731.9 million in 2015 and is expected to
Nanobiotechnology Market to exceed $42.0 Bn by 2021
Zion Research has published a new report titled “Nanobiotechnology Market for Drug Discovery, Drug Delivery, Diagnostics and Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” According to the report, the global nanobiotechnology market was valued at approximately USD 28 billion in 2015 and is expected to reach approximately USD 42 billion by 2021, growing at a CAGR of around 8.5% between 2016 and 2021. Nanobiotechnology Market: Overview Nanobiotechnology
By 2020, Clinical Diagnosis Automation Market to Expand Their Businesses $5.71 B …
Zion Research has published a new report titled “Clinical Diagnosis Automation Market (Modular and Total Lab) Market for Clinical Diagnostics, Drug Discovery, Proteomics Solutions and Other Applications: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the clinical diagnosis automation market was valued at USD 3.12 billion in 2014 and is expected to generate revenue of USD 5.71 billion by end of 2020, growing at

All 5 Releases


More Releases for Metabolomics

Metabolomics Market Competition is Cutthroat over 2025
Global Metabolomics Market: Snapshot Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale. Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four
Metabolomics Market - Global Regional Outlook 2017 - 2025
Global Metabolomics Market: Snapshot Metabolomics is the examination of small molecules, commonly known as metabolites. Such molecules are typically found inside cells, tissues, biofluids, or organisms. The interaction of such small molecules in a biological system are known as the metabolome. Metabolomics is done on a large scale. Metabolomics is a powerful tool since metabolites and their concentrations directly reveal the underlying biochemical activity and condition of cells and tissues. The four
Metabolomics Market Segmentation Analysis
A large pool of players with a robust presence points towards the high degree of competition in the global metabolomics.market Thermo Fisher, Biocrates Life Sciences, Agilent Technologies, Shimadzu, Human Metabolome Technologies, Waters, Metabolon, LECO, Bruker, and Bio-Rad Laboratories are some of the key companies leading this market, finds a new research report by Transparency Market Research (TMR). Hitherto, these companies have relied upon innovation and product advancements for the growth of
Global Metabolomics Market $1.4 Billion by 2021
The global metabolomics market is estimated to reach $1. 4 Billion in 2021, growing at a CAGR of 15.6% from 2017 to 2021, according to a market research report Metabolomics Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. The metabolomics market report estimates the market size (Revenue $million - 2014 to 2021) and key market segments based on detection and separation techniques used, its applications (biomarker discovery, clinical toxicology, drug
Metabolomics Market: Future Demand and Growth Analysis
Metabolomics is the extensive study of small molecules, generally known as metabolites, within cells, biofluids, tissues or organisms. Together, these small molecules and their interactions in a biological system are known as the metabolome. Metabolomics involves the study of substrates and products of metabolism, which are affected by genetic and environmental factors. With the increasing applications of metabolomics in life sciences, the demand is increasing gradually. Metabolomics is gaining more
Metabolomics Market: Overview & Sector Analysis (2016 - 2024)
Biomarker discovery segment to be the largest share of the global metabolomics market The global metabolomics market is segmented on the basis of metabolomics instruments, application, indication, and geography. On the basis of metabolomics instrument, the metabolomics market is segmented into separation technique and detection technique. The separation technique is further segmented into gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra-performance liquid chromatography. The detection technique is further segmented into